OpenURL Connection Search

Select item for more details and to access through your institution.

A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY.
Published in:
Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 21, doi. 10.1093/jcag/gwab002.016
By:
- Peyrin-Biroulet, L;
- Loftus, E V;
- Danese, S;
- Vermeire, S;
- Sandborn, W J;
- Fogel, R;
- Nijhawan, S;
- Kempinski, R;
- Filip, R;
- Hospodarskyy, I;
- McNally, J;
- Yun, C;
- Zhao, S;
- Liu, X;
- Tasset, C;
- Besuyen, R;
- Watanabe, M;
- Schreiber, S;
- Rogler, G;
- Hibi, T
Publication type:
Article
A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY.
Published in:
Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 18, doi. 10.1093/jcag/gwab002.014
By:
- Feagan, B G;
- Loftus, E V;
- Danese, S;
- Vermeire, S;
- Sandborn, W J;
- Ritter, T;
- Mehta, R;
- Seidler, U;
- Seibold, F;
- Beales, I;
- Kim, H;
- McNally, J;
- Yun, C;
- Zhao, S;
- Liu, X;
- Tasset, C;
- Besuyen, R;
- Watanabe, M;
- Schreiber, S;
- Rogler, G
Publication type:
Article
Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
Published in:
Pediatric Nephrology, 2024, v. 39, n. 1, p. 141, doi. 10.1007/s00467-023-06074-x
By:
- Sas, David J.;
- Mara, Kristin;
- Mehta, Ramila A.;
- Seide, Barbara M.;
- Banks, Carly J.;
- Danese, David S.;
- McGregor, Tracy L.;
- Lieske, John C.;
- Milliner, Dawn S.
Publication type:
Article
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer.
Published in:
Oncogene, 2010, v. 29, n. 23, p. 3313, doi. 10.1038/onc.2010.109
By:
- Danese, S.;
- Mantovani, A.
Publication type:
Article
Severe liver injury associated with zafirlukast.
Published in:
2001
By:
- Danese, Silvio;
- de Vitis, Italo;
- Gasbarrini, Antonio;
- Danese, S;
- De Vitis, I;
- Gasbarrini, A
Publication type:
case study
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.
Published in:
2012
By:
- Sorrentino D;
- Terrosu G;
- Paviotti A;
- Geraci M;
- Avellini C;
- Zoli G;
- Fries W;
- Danese S;
- Occhipinti P;
- Croatto T;
- Zarifi D;
- Sorrentino, Dario;
- Terrosu, Giovanni;
- Paviotti, Alberto;
- Geraci, Marco;
- Avellini, Claudio;
- Zoli, Giorgio;
- Fries, Walter;
- Danese, Silvio;
- Occhipinti, Pietro
Publication type:
journal article
Colifagina, a Novel Preparation of 8 Lysed Bacteria Ameliorates Experimental Colitis.
Published in:
International Journal of Immunopathology & Pharmacology, 2008, v. 21, n. 2, p. 401, doi. 10.1177/039463200802100219
By:
- Vetrano, S.;
- Correale, C.;
- Borroni, E.M.;
- Pagano, N.;
- Savino, B.;
- Locati, M.;
- Malesci, A.;
- Repici, A.;
- Danese, S.
Publication type:
Article
Gender, chronic infection and myocardial infarction.
Published in:
2000
By:
- Cremonini, F.;
- Danese, S.;
- Gasbarrini, A.
Publication type:
commentary
Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
Published in:
2012
By:
- Campagnoli C;
- Pasanisi P;
- Abbà C;
- Ambroggio S;
- Biglia N;
- Brucato T;
- Colombero R;
- Danese S;
- Donadio M;
- Venturelli E;
- Zito G;
- Berrino F
Publication type:
Journal Article
ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology.
Published in:
Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 876, doi. 10.1093/ecco-jcc/jjac006
By:
- Magro, F;
- Sabino, J;
- Rosini, F;
- Tripathi, M;
- Borralho, P;
- Baldin, P;
- Danese, S;
- Driessen, A;
- Gordon, I O;
- Iacucci, M;
- Noor, N;
- Svrcek, M;
- Peyrin-Biroulet, L;
- Feakins, R
Publication type:
Article
Segmental Colectomy for Ulcerative Colitis: Is There a Place in Selected Patients Without Active Colitis? An International Multicentric Retrospective Study in 72 Patients.
Published in:
Journal of Crohn's & Colitis, 2020, v. 14, n. 12, p. 1687, doi. 10.1093/ecco-jcc/jjaa107
By:
- Frontali, A;
- Cohen, L;
- Bridoux, V;
- Myrelid, P;
- Sica, G;
- Poggioli, Gilberto;
- Espin, E;
- Beyer-Berjot, L;
- Laharie, D;
- Spinelli, A;
- Zerbib, P;
- Sampietro, G;
- Frasson, M;
- Louis, E;
- Danese, S;
- Fumery, M;
- Denost, Q;
- Altwegg, R;
- Nancey, S;
- Michelassi, F
Publication type:
Article
The prophylactic use of endoscopic vacuum therapy for anastomotic dehiscence after rectal anterior resection: is it feasible for redo surgery?
Published in:
Techniques in Coloproctology, 2022, v. 26, n. 4, p. 319, doi. 10.1007/s10151-021-02566-w
By:
- Mandarino, F. V.;
- Barchi, A.;
- Biamonte, P.;
- Esposito, D.;
- Azzolini, F.;
- Fanti, L.;
- Danese, S.
Publication type:
Article
Obstructed defecation syndrome associated with paradoxical puborectalis contraction: osteopathic treatment versus anal biofeedback. Results of a pilot study.
Published in:
Techniques in Coloproctology, 2021, v. 25, n. 5, p. 589, doi. 10.1007/s10151-020-02381-9
By:
- Ascanelli, S.;
- Portinari, M.;
- Canella, M.;
- Solari, S.;
- Dall'Omo, F.;
- Danese, S.;
- De Troia, A.;
- Carcoforo, P.
Publication type:
Article
Correction to: Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.
Published in:
2020
By:
- Pellino, G.;
- Keller, D. S.;
- Sampietro, G. M.;
- Carvello, M.;
- Celentano, V.;
- Coco, C.;
- Colombo, F.;
- Geccherle, A.;
- Luglio, G.;
- Rottoli, M.;
- Scarpa, M.;
- Sciaudone, G.;
- Sica, G.;
- Sofo, L.;
- Zinicola, R.;
- Leone, S.;
- Danese, S.;
- Spinelli, A.;
- Delaini, G.;
- Selvaggi, F.
Publication type:
Correction Notice
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.
Published in:
2020
By:
- Pellino, G.;
- Keller, D. S.;
- Sampietro, G. M.;
- Annese, V.;
- Carvello, M.;
- Celentano, V.;
- Coco, C.;
- Colombo, F.;
- Cracco, N.;
- Di Candido, F.;
- Franceschi, M.;
- Laureti, S.;
- Mattioli, G.;
- Pio, L.;
- Sciaudone, G.;
- Sica, G.;
- Villanacci, V.;
- Zinicola, R.;
- Leone, S.;
- Danese, S.
Publication type:
Correction Notice
Correction to: Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.
Published in:
2020
By:
- Pellino, G.;
- Keller, D. S.;
- Sampietro, G. M.;
- Angriman, I.;
- Carvello, M.;
- Celentano, V.;
- Colombo, F.;
- Di Candido, F.;
- Laureti, S.;
- Luglio, G.;
- Poggioli, G.;
- Rottoli, M.;
- Scaringi, S.;
- Sciaudone, G.;
- Sica, G.;
- Sofo, L.;
- Leone, S.;
- Danese, S.;
- Spinelli, A.;
- Delaini, G.
Publication type:
Correction Notice
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.
Published in:
Techniques in Coloproctology, 2020, v. 24, n. 5, p. 397, doi. 10.1007/s10151-020-02175-z
By:
- Pellino, G.;
- Keller, D. S.;
- Sampietro, G. M.;
- Carvello, M.;
- Celentano, V.;
- Coco, C.;
- Colombo, F.;
- Geccherle, A.;
- Luglio, G.;
- Rottoli, M.;
- Scarpa, M.;
- Sciaudone, G.;
- Sica, G.;
- Sofo, L.;
- Zinicola, R.;
- Leone, S.;
- Danese, S.;
- Spinelli, A.;
- Delaini, G.;
- Selvaggi, F.
Publication type:
Article
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.
Published in:
Techniques in Coloproctology, 2020, v. 24, n. 5, p. 421, doi. 10.1007/s10151-020-02183-z
By:
- Pellino, G.;
- Keller, D. S.;
- Sampietro, G. M.;
- Angriman, I.;
- Carvello, M.;
- Celentano, V.;
- Colombo, F.;
- Di Candido, F.;
- Laureti, S.;
- Luglio, G.;
- Poggioli, G.;
- Rottoli, M.;
- Scaringi, S.;
- Sciaudone, G.;
- Sica, G.;
- Sofo, L.;
- Leone, S.;
- Danese, S.;
- Spinelli, A.;
- Delaini, G.
Publication type:
Article
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.
Published in:
Techniques in Coloproctology, 2020, v. 24, n. 2, p. 105, doi. 10.1007/s10151-019-02145-0
By:
- Pellino, G.;
- Keller, D. S.;
- Sampietro, G. M.;
- Annese, V.;
- Carvello, M.;
- Celentano, V.;
- Coco, C.;
- Colombo, F.;
- Cracco, N.;
- Di Candido, F.;
- Franceschi, M.;
- Laureti, S.;
- Mattioli, G.;
- Pio, L.;
- Sciaudone, G.;
- Sica, G.;
- Villanacci, V.;
- Zinicola, R.;
- Leone, S.;
- Danese, S.
Publication type:
Article
Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2009, v. 29, n. 9, p. 921, doi. 10.1111/j.1365-2036.2009.03955.x
By:
- FIORINO, G.;
- ALLEZ, M.;
- MALESCI, A.;
- DANESE, S.
Publication type:
Article
Increased carotid intima–media thickness in patients with inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 22, n. 9, p. 839, doi. 10.1111/j.1365-2036.2005.02657.x
By:
- PAPA, A.;
- SANTOLIQUIDO, A.;
- DANESE, S.;
- COVINO, M.;
- CAMPLI, C. Di;
- URGESI, R.;
- GRILLO, A.;
- GUGLIELMO, S.;
- TONDI, P.;
- GUIDI, L.;
- VITIS, I. DE;
- FEDELI, G.;
- GASBARRINI, G.;
- GASBARRINI, A.
Publication type:
Article
Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2000, v. 14, n. 11, p. 1403, doi. 10.1046/j.1365-2036.2000.00860.x
By:
- Papa, A.;
- Danese, S.;
- Gasbarrini, A.;
- Gasbarrini, G.
Publication type:
Article
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines.
Published in:
2005
By:
- Berruti, A;
- Bitossi, R;
- Gorzegno, G;
- Bottini, A;
- Generali, D;
- Milani, M;
- Katsaros, D;
- Rigault de la Longrais, I A;
- Bellino, R;
- Donadio, M;
- Ardine, M;
- Bertetto, O;
- Danese, S;
- Sarobba, M G;
- Farris, A;
- Lorusso, V;
- Dogliotti, L
Publication type:
journal article
Editorial: antigenic response to CT‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars. Authors’ reply.
Published in:
2018
By:
- Goncalves, J.;
- Magro, F.;
- Danese, S.;
- Lakatos, P. L.;
- Ben‐Horin, S.
Publication type:
Editorial
Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 6, p. 773, doi. 10.1111/apt.14514
By:
- Olivera, P.;
- Sandborn, W. J.;
- Panés, J.;
- Baumann, C.;
- D'Haens, G.;
- Vermeire, S.;
- Danese, S.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Editorial: tofacitinib and biologics for moderate‐to‐severe ulcerative colitis—what is best in class? Authors’ reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 540, doi. 10.1111/apt.14486
By:
- Bonovas, S.;
- Lytras, T.;
- Nikolopoulos, G.;
- Peyrin‐Biroulet, L.;
- Danese, S.
Publication type:
Article
Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 454, doi. 10.1111/apt.14449
By:
- Bonovas, S.;
- Lytras, T.;
- Nikolopoulos, G.;
- Peyrin‐Biroulet, L.;
- Danese, S.
Publication type:
Article
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 9, p. 903, doi. 10.1111/apt.14262
By:
- Fiorino, G.;
- Correale, C.;
- Radice, S.;
- Allocca, M.;
- Furfaro, F.;
- Gilardi, D.;
- Nagore, D.;
- Del Rio, L.;
- Pascual, J.;
- Martínez, A.;
- Danese, S.
Publication type:
Article
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply.
Published in:
2017
By:
- Bonovas, S.;
- Fiorino, G.;
- Lytras, T.;
- Nikolopoulos, G.;
- Peyrin‐Biroulet, L.;
- Danese, S.
Publication type:
Editorial
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 9, p. 1179, doi. 10.1111/apt.14023
By:
- Bonovas, S.;
- Fiorino, G.;
- Lytras, T.;
- Nikolopoulos, G.;
- Peyrin‐Biroulet, L.;
- Danese, S.
Publication type:
Article
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 8, p. 1058, doi. 10.1111/apt.13995
By:
- Allen, P. B.;
- Olivera, P.;
- Emery, P.;
- Moulin, D.;
- Jouzeau, J.‐Y.;
- Netter, P.;
- Danese, S.;
- Feagan, B.;
- Sandborn, W. J.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Review article: the histological assessment of disease activity in ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 8, p. 957, doi. 10.1111/apt.13375
By:
- Marchal Bressenot, A.;
- Riddell, R. H.;
- Boulagnon‐Rombi, C.;
- Reinisch, W.;
- Danese, S.;
- Schreiber, S.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 6, p. 664, doi. 10.1111/apt.13322
By:
- Tursi, A.;
- Papa, A.;
- Danese, S.
Publication type:
Article
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 11, p. 1055, doi. 10.1111/apt.13190
By:
- Moja, L.;
- Danese, S.;
- Fiorino, G.;
- Del Giovane, C.;
- Bonovas, S.
Publication type:
Article
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 5, p. 409, doi. 10.1111/apt.13076
By:
- Sandborn, W. J.;
- Danese, S.;
- D'Haens, G.;
- Moro, L.;
- Jones, R.;
- Bagin, R.;
- Huang, M.;
- David Ballard, E.;
- Masure, J.;
- Travis, S.
Publication type:
Article
Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease.
Published in:
2014
By:
- Cesarini, M.;
- Danese, S.
Publication type:
Editorial
Review article: optimal preparation for surgery in Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 9, p. 1009, doi. 10.1111/apt.12947
By:
- Spinelli, A.;
- Allocca, M.;
- Jovani, M.;
- Danese, S.
Publication type:
Article
Commentary: adjunct antibiotic combination therapy for ulcerative colitis - is it time to investigate Fusobacterium varium?
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 11, p. 1333, doi. 10.1111/apt.12742
By:
- Fiorino, G.;
- Danese, S.
Publication type:
Article
Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 10, p. 1095, doi. 10.1111/apt.12712
By:
- Danese, S.;
- Siegel, C. A.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 7, p. 743, doi. 10.1111/apt.12648
By:
- Gomollón, F.;
- Chowers, Y.;
- Danese, S.;
- Dignass, A.;
- Haagen Nielsen, O.;
- Lakatos, P. L.;
- Lees, C. W.;
- Lindgren, S.;
- Lukas, M.;
- Mantzaris, G. J.;
- Michetti, P.;
- Moum, B.;
- Peyrin‐Biroulet, L.;
- Toruner, M.;
- Woude, J.;
- Weiss, G.;
- Stoevelaar, H.;
- Reinisch, W.
Publication type:
Article
Commentary: anaemia in inflammatory bowel disease - the most common and ignored extra intestinal manifestation.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 2, p. 227, doi. 10.1111/apt.12578
By:
- Fiorino, G.;
- Allocca, M.;
- Danese, S.
Publication type:
Article
The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 9, p. 1109, doi. 10.1111/apt.12493
By:
- Reinisch, W.;
- Chowers, Y.;
- Danese, S.;
- Dignass, A.;
- Gomollón, F.;
- Haagen Nielsen, O.;
- Lakatos, P. L.;
- Lees, C. W.;
- Lindgren, S.;
- Lukas, M.;
- Mantzaris, G. J.;
- Michetti, P.;
- Moum, B.;
- Peyrin‐Biroulet, L.;
- Toruner, M.;
- Woude, J.;
- Weiss, G.;
- Stoevelaar, H.
Publication type:
Article
Commentary: antibodies reacting with the infliximab Fab portion - something new?
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 5, p. 552, doi. 10.1111/apt.12401
By:
- Allocca, M.;
- Fiorino, G.;
- Danese, S.
Publication type:
Article
Review article: the role of anti-TNF in the management of ulcerative colitis - past, present and future.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 9, p. 855, doi. 10.1111/apt.12284
By:
- Danese, S.;
- Colombel, J.‐F.;
- Peyrin‐Biroulet, L.;
- Rutgeerts, P.;
- Reinisch, W.
Publication type:
Article
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 8, p. 840, doi. 10.1111/apt.12256
By:
- Indriolo, A.;
- Fagiuoli, S.;
- Pasulo, L.;
- Fiorino, G.;
- Danese, S.;
- Ravelli, P.
Publication type:
Article
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 2, p. 277, doi. 10.1111/apt.12136
By:
- Jovani, M.;
- Fiorino, G.;
- Danese, S.
Publication type:
Article
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 1, p. 1, doi. 10.1111/j.1365-2036.2011.04679.x
By:
- Danese, S.;
- Fiorino, G.;
- Reinisch, W.
Publication type:
Article
Review article: infliximab for Crohn's disease treatment - shifting therapeutic strategies after 10 years of clinical experience.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 8, p. 857, doi. 10.1111/j.1365-2036.2011.04598.x
By:
- Danese, S.;
- Colombel, J.‐F.;
- Reinisch, W.;
- Rutgeerts, P. J.
Publication type:
Article
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn’s disease: authors’ reply.
Published in:
2010
By:
- Szabò, H.;
- Fiorino, G.;
- Danese, S.
Publication type:
Letter
Review article: anti-fibrotic agents for the treatment of Crohn’s disease – lessons learnt from other diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 2, p. 189, doi. 10.1111/j.1365-2036.2009.04171.x
By:
- SZABÒ, H.;
- FIORINO, G.;
- SPINELLI, A.;
- ROVIDA, S.;
- REPICI, A.;
- MALESCI, A. C.;
- DANESE, S.
Publication type:
Article

Found: 58